Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01062035 · ClinicalTrials.gov registry record
Study of a Screening Blood Test to Determine Patients' Potential Risk of Adenomatous or Advanced Colon Polyps (ACPs)
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 72
- Enrollment target
NCT01062035: Completed study, sponsored by Mayo Clinic.
NCT01062035 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 72 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01062035 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 72 participants
- Enrollment target
Study Summary
The aim of this study is to develop a blood test to determine which patients are at risk for pre-cancerous colon polyps (ACPs: Advanced Colon Polyps). The telomere length of peripheral blood lymphocytes (PBLs) can be measured from a blood sample. Mechanistic pathways and the investigator's preliminary data support PBL telomere length as a biomarker for ACPs. The long-term goal of this project is to decrease deaths from colon cancer by using a blood test to target colonoscopy for those patients who are at high risk for pre-cancerous polyps.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2010-01 |
| Est. Completion | 2013-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01062035
The ClinicalTrials.gov registry entry for NCT01062035 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01062035 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01062035 about?
NCT01062035 is a clinical study titled "Study of a Screening Blood Test to Determine Patients' Potential Risk of Adenomatous or Advanced Colon Polyps (ACPs)". The aim of this study is to develop a blood test to determine which patients are at risk for pre-cancerous colon polyps (ACPs: Advanced Colon Polyps). The telomere length of peripheral blood lymphocytes (PBLs) can be measured from a blood sample. Mechanistic pathways and the investigator's prelimina...
What is the current status of trial NCT01062035?
This trial is currently completed. The enrollment target is 72 participants. The study started on 2010-01. Estimated completion is 2013-09.
Who is sponsoring clinical trial NCT01062035?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.